New stroke drug shows promise in early safety trial
NCT ID NCT06447415
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new medicine called HRS-7450 in 64 adults who had a stroke within the past 4.5 to 24 hours. The goal was to check if the drug is safe and might help restore blood flow to the brain. Researchers monitored for bleeding and other side effects to see if the treatment is worth testing in larger studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Sun Yat sen University
Guangzhou, Guangdong, 510062, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can a drug boost brain recovery after stroke?
- Can a blood Clot's inflammation predict stroke recovery?
- Can a new infusion drug boost stroke recovery?
- Can removing clots from tiny brain arteries boost stroke recovery?
- Could vague stroke symptoms delay lifesaving treatment?